Therapeutics and Clinical Risk Management. 2008 Feb;4(1):205-11. [Link]

Goudar RK.

Department of Medicine, Division of Hematology, Medical Oncology and Cellular Therapy, Duke University Medical Center, Durham, NC, USA.

Abstract

Malignant pleural mesothelioma is a resistant form of lung cancer, and its incidence continues to rise in Europe and Australia. Until recently, chemotherapy had not been shown to be effective in the treatment of this slowly progressive disease. In 2004, the combination of pemetrexed and cisplatin was shown to induce high response rates in MPM. This article reviews the published literature describing the development and testing of this therapeutic combination in mesothelioma, and examines in detail the key phase III clinical trial that led to the approval of pemetrexed by the US FDA. Ongoing research will further define the role of pemetrexed plus cisplatin in the treatment of MPM.

Keywords: malignant pleural mesothelioma, mesothelioma, pemetrexed, cisplatin

August 30, 2008 | Comments Off on

Therapeutics and Clinical Risk Management. 2008 Feb;4(1):205-11. [Link]

Goudar RK.

Department of Medicine, Division of Hematology, Medical Oncology and Cellular Therapy, Duke University Medical Center, Durham, NC, USA.

Abstract

Malignant pleural mesothelioma is a resistant form of lung cancer, and its incidence continues to rise in Europe and Australia. Until recently, chemotherapy had not been shown to be effective in the treatment of this slowly progressive disease. In 2004, the combination of pemetrexed and cisplatin was shown to induce high response rates in MPM. This article reviews the published literature describing the development and testing of this therapeutic combination in mesothelioma, and examines in detail the key phase III clinical trial that led to the approval of pemetrexed by the US FDA. Ongoing research will further define the role of pemetrexed plus cisplatin in the treatment of MPM.

Keywords: malignant pleural mesothelioma, mesothelioma, pemetrexed, cisplatin

Therapeutics and Clinical Risk Management. 2008 Feb;4(1):205-11. [Link] Goudar RK. Department of Medicine, Division of Hematology, Medical Oncology and Cellular Therapy, Duke University Medical Center, Durham, NC, USA. Abstract Malignant…

Metastatic appendiceal mucinous adenocarcinoma to well-differentiated diffuse mesothelioma of the peritoneal cavity: a mimicker of florid mesothelial hyperplasia in association with neoplasms

August 30, 2008 | Comments Off on Metastatic appendiceal mucinous adenocarcinoma to well-differentiated diffuse mesothelioma of the peritoneal cavity: a mimicker of florid mesothelial hyperplasia in association with neoplasms

International Journal of Gynecological Pathology. 2008 Oct;27(4):526-30. [Link] Tran TA, Holloway RW, Finkler NJ. Department of Pathology, Florida Hospital Orlando, Orlando, Florida 32803, USA. trannguyentienanh@hotmail.com Abstract Atypical/florid mesothelial hyperplasia associated…

Novel Oncolytic Agent GLV-1h68 Is Effective Against Malignant Pleural Mesothelioma

August 30, 2008 | Comments Off on Novel Oncolytic Agent GLV-1h68 Is Effective Against Malignant Pleural Mesothelioma

Human Gene Therapy. 2008 Aug;19(8):774-82. [Link] Kelly KJ, Woo Y, Brader P, Yu Z, Riedl C, Lin SF, Chen N, Yu YA, Rusch VW, Szalay AA, Fong Y. Department of…

Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2

August 30, 2008 | Comments Off on Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2

Cancer Science. 2008 Aug;99(8):1603-10. [Link] Yamada T, Yano S, Ogino H, Ikuta K, Kakiuchi S, Hanibuchi M, Kanematsu T, Taniguchi T, Sekido Y, Sone S. Department of Internal Medicine and…

Alterations in manganese, copper, and zinc contents, and intracellular status of the metal-containing superoxide dismutase in human mesothelioma cells

August 30, 2008 | Comments Off on Alterations in manganese, copper, and zinc contents, and intracellular status of the metal-containing superoxide dismutase in human mesothelioma cells

Journal of Trace Elements in Medicine and Biology. 2008;22(3):248-55. Epub 2008 Jul 18. [Link] Hasegawa S, Koshikawa M, Takahashi I, Hachiya M, Furukawa T, Akashi M, Yoshida S, Saga T.…

Asbestos clinics and asbestos health examinations–findings from a questionnaire survey of implementing organizations

August 23, 2008 | Comments Off on Asbestos clinics and asbestos health examinations–findings from a questionnaire survey of implementing organizations

Sangyo Eiseigaku Zasshi. 2008 Sep;50(5):145-51. Epub 2008 Aug 22. [Link] Nagao N, Nishikawa K, Kiyomoto Y, Todoroki M, Hoshuyama T, Takahashi K. Department of Emergency, Kansai Rosai Hospital, Japan. Abstract…

Successful palliation of malignant ascites from peritoneal mesothelioma by laparoscopic intraperitoneal hyperthermic chemotherapy

August 22, 2008 | Comments Off on Successful palliation of malignant ascites from peritoneal mesothelioma by laparoscopic intraperitoneal hyperthermic chemotherapy

Surgical Laparoscopy, Endoscopy & Percutaneous Techniques. 2008 Aug;18(4):426-8. [Link] Patriti A, Cavazzoni E, Graziosi L, Pisciaroli A, Luzi D, Gullà N, Donini A. Section of General and Emergency Surgery, Department…

Primary malignant mesothelioma developed in liver

August 19, 2008 | Comments Off on Primary malignant mesothelioma developed in liver

Hepato-gastroenterology. 2008 May-Jun;55(84):1081-4. [Link] Kim DS, Lee SG, Jun SY, Kim KW, Ha TY, Kim KK. Division of Transplantation and Hepatobiliary Surgery, Department of Surgery, University of Cincinnati, Cincinnati, OH,…

Rectus abdominis muscle resection for abdominal wall recurrence of mucinous adenocarcinoma or peritoneal mesothelioma

August 19, 2008 | Comments Off on Rectus abdominis muscle resection for abdominal wall recurrence of mucinous adenocarcinoma or peritoneal mesothelioma

Tumori. 2008 May-Jun;94(3):309-13.[Link] Yan T, Sugarbaker P. Peritoneal Surface Malignancy Program, Washington Cancer Institute, Washington Hospital Center, Washington, DC 20010, USA. Abstract Aims and Background: Diagnostic technologies which penetrate the…

Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis

August 19, 2008 | Comments Off on Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis

Current Treatment Options in Oncology. 2008 Aug 15. [Epub ahead of print] [Link] Yang H, Testa JR, Carbone M. Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HI, 96813,…

Categories